Marginal Ulcer
7
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
29%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
OPEN Versus InTact Capsule Proton Pump Inhibitors for the Treatment of Marginal Ulcers
Outcome Analysis of POEM and Endoluminal Therapies
Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment
Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding
Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
Chronic Marginal Ulcers After Gastric Bypass
Perforated Marginal Ulcer After Gastric Bypass